A452, an HDAC6 ‐selective inhibitor, synergistically enhances the anticancer activity of chemotherapeutic agents in colorectal cancer cells

Molecular Carcinogenesis, EarlyView.

Source: Molecular Carcinogenesis - June 23, 2018 Category: Molecular Biology Authors: Hye ‐Rim Won , Hyun‐Wook Ryu , Dong‐Hee Shin , Soo‐Keun Yeon , Dong Hoon Lee , So Hee Kwon Source Type: research